Works by Nowakowski, Grzegorz S.

Results: 93
    1

    Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01322-9
    By:
    • Atallah-Yunes, Suheil Albert;
    • Rees, Matthew J.;
    • Mwangi, Raphael;
    • Kuchler, Robyn L.;
    • Alnughmush, Ahmed;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Villasboas Bisneto, Jose C.;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    2
    3

    Safety and efficacy of durvalumab with R-CHOP or R<sup>2</sup>-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial.

    Published in:
    International Journal of Hematology, 2022, v. 115, n. 2, p. 222, doi. 10.1007/s12185-021-03241-4
    By:
    • Nowakowski, Grzegorz S.;
    • Willenbacher, Wolfgang;
    • Greil, Richard;
    • Larsen, Thomas S.;
    • Patel, Krish;
    • Jäger, Ulrich;
    • Manges, Robert F.;
    • Trümper, Lorenz;
    • Everaus, Hele;
    • Kalakonda, Nagesh;
    • Brown, Peter;
    • Jørgensen, Judit Meszaros;
    • Cunningham, David;
    • Dell'Aringa, Justine;
    • Fox, Brian;
    • Rubio, Neus Domper;
    • Kilavuz, Nurgul;
    • Casadebaig, Marie-Laure;
    • Manzke, Oliver;
    • Munoz, Javier
    Publication type:
    Article
    4
    5

    Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 606, doi. 10.1002/ajh.27630
    By:
    • Yamshon, Samuel;
    • Koff, Jean L.;
    • Larson, Melissa C.;
    • Kahl, Brad S.;
    • Casulo, Carla;
    • Lossos, Izidore S.;
    • Haddadi, Sara;
    • Stanchina, Michele;
    • Chihara, Dai;
    • Ayers, Amy;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Khurana, Arushi;
    • Nowakowski, Grzegorz S.;
    • Reicks, Tanner W.;
    • Farooq, Umar;
    • Link, Brian K.;
    • Cohen, Jonathon B.;
    • Martin, Peter;
    • Li, Jia
    Publication type:
    Article
    6
    7

    Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
    By:
    • Hess, Brian T.;
    • Giri, Anshu;
    • Park, Yeonhee;
    • Patel, Krina K.;
    • Link, Brian K.;
    • Nowakowski, Grzegorz S.;
    • Maliske, Seth M.;
    • Fortin, Sonia;
    • Chavez, Julio C.;
    • Saeed, Hayder;
    • Hill, Brian T.;
    • Mejia Garcia, Alex V.;
    • Maddocks, Kami J.;
    • Hanel, Walter;
    • Wagner‐Johnston, Nina D.;
    • Messmer, Marcus R.;
    • Kahl, Brad S.;
    • Watkins, Marcus;
    • Alderuccio, Juan Pablo;
    • Lossos, Izidore S.
    Publication type:
    Article
    8

    Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
    By:
    • Seegobin, Karan;
    • Li, Zhuo;
    • Alhaj Moustafa, Muhamad;
    • Majeed, Umair;
    • Wang, Jing;
    • Jiang, Liuyan;
    • Kuhlman, Justin;
    • Menke, David;
    • Li, Ke;
    • Kharfan‐Dabaja, Mohamed A.;
    • Ayala, Ernesto;
    • Iqbal, Madiha;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Johnston, Patrick;
    • Thompson, Carrie;
    • Ansell, Stephen;
    • Tun, Han W.
    Publication type:
    Article
    9

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    10

    Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
    By:
    • Higgins, Alexandra;
    • Kim, Hidong;
    • Harper, Laura;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Johnston, Patrick;
    • Witzig, Thomas E.;
    • Allmer, Cristine;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Young, Jason R.;
    • Thanarajasingam, Gita
    Publication type:
    Article
    11
    12
    13

    Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
    By:
    • Castellino, Alessia;
    • Pulido, Jose S.;
    • Johnston, Patrick B.;
    • Ristow, Kay M.;
    • Nora Bennani, N.;
    • Inwards, David J.;
    • Macon, William R.;
    • Micallef, Ivana N. M.;
    • King, Rebecca L.;
    • Salomao, Diva R.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    14
    15

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    16

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    17

    Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
    By:
    • Maurer, Matthew J.;
    • Bachy, Emmanuel;
    • Ghesquières, Hervé;
    • Ansell, Stephen M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Inwards, David J.;
    • Allmer, Cristine;
    • Chassagne-Clément, Catherine;
    • Nicolas-Virelizier, Emmanuelle;
    • Sebban, Catherine;
    • Lebras, Laure;
    • Sarkozy, Clementine;
    • Macon, William R.;
    • Feldman, Andrew L.;
    • Syrbu, Sergei I.;
    • Traverse-Glehan, Alexandra;
    • Coiffier, Bertrand;
    • Slager, Susan L.;
    • Weiner, George J.
    Publication type:
    Article
    18

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    19
    20

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    21

    Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
    By:
    • Bock, Allison M.;
    • Gile, Jennifer J.;
    • Larson, Melissa C.;
    • Poonsombudlert, Kittika;
    • Tawfiq, Reema K.;
    • Maliske, Seth;
    • Maurer, Matthew J.;
    • Kabat, Brian F.;
    • Paludo, Jonas;
    • Inwards, David J.;
    • Ayyappan, Sabarish;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Cerhan, James R.;
    • Farooq, Umar;
    • Wang, Yucai
    Publication type:
    Article
    22
    23
    24

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    25
    26

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    27

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
    By:
    • Arushi Khurana;
    • Mwangi, Raphael;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Strouse, Christopher;
    • Link, Brian K.;
    • Wang, Yucai;
    • King, Rebecca L.;
    • Macon, William R.;
    • Villasboas, J. C.;
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    28
    29

    Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
    By:
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Manske, Michelle K.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Larson, Melissa C.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • McPhail, Ellen;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • King, Rebecca L.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    30

    Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
    By:
    • Wang, Yucai;
    • Wenzl, Kerstin;
    • Manske, Michelle K.;
    • Asmann, Yan W.;
    • Sarangi, Vivekananda;
    • Greipp, Patricia T.;
    • Krull, Jordan E.;
    • Hartert, Keenan;
    • He, Rong;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Slager, Susan L.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    31
    32
    33
    34
    35

    Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1221, doi. 10.1093/cid/ciz940
    By:
    • Fama, Angelo;
    • Larson, Melissa C;
    • Link, Brian K;
    • Habermann, Thomas M;
    • Feldman, Andrew L;
    • Call, Timothy G;
    • Ansell, Stephen M;
    • Liebow, Mark;
    • Xiang, Jinhua;
    • Maurer, Matthew J;
    • Slager, Susan L;
    • Nowakowski, Grzegorz S;
    • Stapleton, Jack T;
    • Cerhan, James R
    Publication type:
    Article
    36
    37

    P632: COMPARISON OF TREATMENT‐EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B‐CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META‐ANALYSIS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969432.47546.cf
    By:
    • Hwang, Steven;
    • Wang, Jacqueline;
    • Tian, Zizhong;
    • Qi, Xinyue;
    • Jiang, Yi;
    • Zhang, Shijia;
    • Godby, Richard C.;
    • Parikh, Sameer;
    • Ding, Wei;
    • Hampel, Paul;
    • Munoz, Javier;
    • Paludo, Jonas;
    • Kenderian, Saad;
    • Muchtar, Eli;
    • Tsang, Mazie;
    • Hilal, Talal;
    • Leis, Jose;
    • Thanarajasingam, Gita;
    • Inwards, David;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    38
    39
    40
    41

    Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 3, p. 573, doi. 10.1080/10428194.2022.2160200
    By:
    • Van Le, Hoa;
    • Van Naarden Braun, Kim;
    • Nowakowski, Grzegorz S.;
    • Sermer, David;
    • Radford, John;
    • Townsend, William;
    • Ghesquieres, Herve;
    • Menne, Tobias;
    • Porpaczy, Edit;
    • Fox, Christopher P.;
    • Schusterbauer, Claudia;
    • Liu, Fei Fei;
    • Yue, Lihua;
    • De Benedetti, Marc;
    • Hasskarl, Jens
    Publication type:
    Article
    42

    A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2625, doi. 10.1080/10428194.2021.1938027
    By:
    • Collins, Graham P.;
    • Clevenger, Tracy N.;
    • Burke, Kathleen A.;
    • Yang, Buyue;
    • MacDonald, Alex;
    • Cunningham, David;
    • Fox, Christopher P.;
    • Goy, Andre;
    • Gribben, John;
    • Nowakowski, Grzegorz S.;
    • Roschewski, Mark;
    • Vose, Julie M.;
    • Vallurupalli, Anusha;
    • Cheung, Jean;
    • Raymond, Amelia;
    • Nuttall, Barrett;
    • Stetson, Dan;
    • Dougherty, Brian A.;
    • Schalkwijk, Stein;
    • Carnevalli, Larissa S.
    Publication type:
    Article
    43

    Analysis and impact of a multidisciplinary lymphoma virtual tumor board.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 14, p. 3351, doi. 10.1080/10428194.2020.1817432
    By:
    • Habermann, Thomas M.;
    • Khurana, Arushi;
    • Lentz, Ruth;
    • Schmitz, John J.;
    • von Bormann, Alexander G.;
    • Young, Jason R.;
    • Hunt, Christopher H.;
    • Christofferson, Sara N.;
    • Nowakowski, Grzegorz S.;
    • McCullough, Kristen B.;
    • Horna, Pedro;
    • Wood, Adam J.;
    • Macon, William R.;
    • Kurtin, Paul J.;
    • Lester, Scott C.;
    • Stafford, Scott L.;
    • Chamarthy, Ushrasree;
    • Khan, Faraz;
    • Ansell, Stephen M.;
    • King, Rebecca L.
    Publication type:
    Article
    44

    Predictors of short-term survival in Waldenström Macroglobulinemia.

    Published in:
    2020
    By:
    • Ruan, Gordon;
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie;
    • Go, Ronald S.;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Paludo, Jonas;
    • Thanarajasingam, Gita;
    • Inwards, David J.;
    • Thompson, Carrie A.;
    • Habermann, Thomas M.;
    • Lin, Yi;
    • Nowakowski, Grzegorz S.;
    • Bisneto, Jose C. Villasboas;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Dingli, David
    Publication type:
    Letter
    45
    46
    47

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    48
    49

    Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 11, p. 2159, doi. 10.3109/10428194.2012.690605
    By:
    • Porrata, Luis F.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Ozsan, Nazan;
    • Dogan, Ahmet;
    • Macon, William;
    • Colgan, Joseph P.;
    • Witzig, Thomas E.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie;
    • Markovic, Svetomir N.
    Publication type:
    Article
    50